Ginna Laport
Direttore Tecnico/Scientifico/R&S presso CARGO THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Ginna G.
Laport is currently the Chief Medical Officer at Cargo Therapeutics, Inc. She previously held positions as the National Chairman at Blood & Marrow Transplant Clinical Trials Network, Vice President-Clinical Development at Genentech, Inc., Vice President-Clinical Development at Corvus Pharmaceuticals, Inc., Assistant Professor at the University of Pennsylvania, and Professor at Stanford University School of Medicine.
She also served as the Chief Medical Officer at Tempest Therapeutics, Inc. Dr. Laport completed her undergraduate degree at Baylor University and her doctorate at The University of Texas at Austin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
-.--% | 05/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Ginna Laport
| Società | Posizione | Inizio |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 17/10/2023 |
Precedenti posizioni note di Ginna Laport
| Società | Posizione | Fine |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/10/2023 |
| TEMPEST THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
| CORVUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2018 |
| Stanford University School of Medicine | Corporate Officer/Principal | 01/10/2015 |
| University of Pennsylvania | Corporate Officer/Principal | 01/01/2001 |
Formazione di Ginna Laport
| The University of Texas at Austin | Doctorate Degree |
| Baylor University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| TEMPEST THERAPEUTICS, INC. | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| Blood & Marrow Transplant Clinical Trials Network | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Ginna Laport
